ClinicalTrials.gov
public full text
Public Domain
A Phase 1 Trial of OPA-15406 Ointment in Healthy Adult Male Subjects
To assess the safety (especially skin findings) and pharmacokinetics by applying 0.3%, 1%, or 3% formulation of 5g OPA-15406 ointment to a 1000 cm2 area as a single-dose and as a multiple-dose twice daily for 2 weeks in Japanese healthy adult male subjects.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Intra-anal Oxymetazoline in Healthy Adult Volunteers#1060004
- Long-term Trial of OPA-15406 Ointment in Adult and Pediatric Patients With Atopic Dermatitis#1137892
- A Long-term Trial of OPA-15406 in Infants With Atopic Dermatitis#828069
- Topical Hydromorphone for Wound Healing#838504
- Phase 1 Single Ascending Doses (SAD) of M5542 in Healthy Participants#1101911
Record · ID 1058282
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive